Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CYCC - Cyclacel Pharmaceuticals EPS misses by $2.21


CYCC - Cyclacel Pharmaceuticals EPS misses by $2.21

Cyclacel Pharmaceuticals (CYCC): Q4 GAAP EPS of -$2.74 misses by $2.21.As of December 31, 2020, cash and cash equivalents totaled $33.4 million. Additional proceeds of $4.3 million were received from the exercise of warrants after December 31, 2020. Based on current spending, the proforma cash on hand of $37.7 million provides the Company with sufficient resources to fund planned operations including research and development through early 2023.Press Release

For further details see:

Cyclacel Pharmaceuticals EPS misses by $2.21
Stock Information

Company Name: Cyclacel Pharmaceuticals Inc.
Stock Symbol: CYCC
Market: NASDAQ
Website: cyclacel.com

Menu

CYCC CYCC Quote CYCC Short CYCC News CYCC Articles CYCC Message Board
Get CYCC Alerts

News, Short Squeeze, Breakout and More Instantly...